02 September 2024
Samarkand Group plc
("Samarkand", the "Company" or together with its subsidiaries the "Group")
Publication of Annual Report and Notice of AGM
Samarkand Group plc, (AQSE: SMK), the cross-border eCommerce technology solution provider, is pleased to announce that it has published its Annual Report and Accounts for the year ended 31 March 2024 ("Annual Report").
The Company announces that notice convening the Company's Annual General Meeting ("Notice of AGM"), to be held at 1:00 pm on Thursday 26 September 2024 at Unit 13 Tonbridge Trade Park, Ingot Way, Tonbridge, TN9 1GN, has been posted to shareholders on 30 August 2024, together with the Annual Report.
Copies of the Annual Report and the Notice of AGM are also available on the Company's website at www.samarkand.global/investors
For more information, please contact:
| Samarkand Group plc | http://samarkand.global/ |
| David Hampstead, Chief Executive Officer Eva Hang, Chief Financial Officer | info@samarkand.global |
| | |
| Guild Financial Advisory Limited | |
| Ross Andrews Tomas Klaassen | +44 (0) 7973839767 +44 (0) 7834458095 |
|
| |
| | |
| |
|
Notes to Editors
Samarkand is a consumer brand owner and distributor operating a scale up platform for niche, premium, multichannel, health and healing brands. Core owned brands include Napiers the Herbalists, Scotland's oldest natural herbal apothecary and Zita West, a leading specialist supplement line for fertility and reproductive health. Platform services include marketing, sales and channel development with a focus on social commerce, China market entry, international expansion and manufacturing. In addition, the group works as the exclusive China market partner for a select portfolio of niche luxury skin care brands and connects these brands to the Chinese consumer via cross border eCommerce.
Founded in 2016, Samarkand is headquartered in Tonbridge, UK with offices in Shanghai.
For further information please visit https://www.samarkand.global/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
